SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-055509
Filing Date
2018-09-06
Accepted
2018-09-06 10:40:26
Documents
1
Period of Report
2018-09-04

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 12736
  Complete submission text file 0001104659-18-055509.txt   14126
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address DORSET MANAGEMENT CORP 485 UNDERHILL BLVD SUITE 205 SYOSSET NY 11791
Business Address
Sabba Stephen L (Reporting) CIK: 0001442372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 181056913